Velentium vs Delve: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of Delve (4.0/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. Delve is the stronger option for user research and industrial design for medtech. The right choice depends on your project size, budget, and required tech stack.
Velentium vs Delve: head-to-head summary
| Criterion | Velentium | Delve |
|---|---|---|
| Founded | 2012 | 2021 |
| HQ | Katy, TX, USA | Madison, WI, USA |
| Team size | 51–250 | 200–500 |
| Rating | 4.5 / 5 | 4.0 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | Design research and industrial design depth from two long-established US studios |
| Pricing model | Fixed project, time and materials, manufacturing contract | Time and materials, phased fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | SolidWorks, Usability engineering, Rapid prototyping |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial |
Velentium vs Delve: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
Delve
Delve is a product design and innovation firm headquartered in Madison, Wisconsin, with studios in Boston, Philadelphia and San Francisco. Trinity Hunt Partners bought it in 2021 and merged it with Philadelphia's Bresslergroup (founded 1970), and the combined business now operates under the Delve name and later acquired digital design firm altr. Its team is estimated at 200 to 500 people. Delve says it designed and engineered the Dexcom G6 continuous glucose monitor (per company website; independently unverifiable), and medical devices are a large share of its work alongside consumer and industrial products.
Services and capabilities: Velentium vs Delve
| Capability | Velentium | Delve |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✓ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✗ |
| Manufacturing & scale-up | ✓ | ✗ |
Tech stack comparison: Velentium vs Delve
| Framework / platform | Velentium | Delve |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | N/A |
| Qt | N/A | N/A |
Pricing comparison: Velentium vs Delve
| Criterion | Velentium | Delve |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs Delve
| Dimension | Velentium | Delve |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Industrial design and user research for a wearable, Human factors work on a home-use device |
| Typical project type | Fixed project | Consulting |
Velentium vs Delve: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| Delve | |
|---|---|
| + | Strong user research and industrial design, important for patient-worn devices |
| + | Multiple US studios |
| + | Public wearable CGM experience |
| + | Bresslergroup brings a long patent and design-award record |
| - | Private-equity owned since 2021 and built through mergers |
| - | Medical is a large share, but consumer and industrial work compete for attention |
| - | ISO 13485 certification was not confirmed in our research |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose Delve?
A typical fit: industrial design and user research for a wearable.
Design research and industrial design depth from two long-established US studios. Minimum engagement is not publicly disclosed. Works best with clients in Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial.
Decision matrix: Velentium vs Delve
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs Delve (Not disclosed) |
| You need specialist depth in a specific vertical | Delve |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs Delve
| Use case | Velentium fit | Delve fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Limited | Velentium |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Industrial design and user research for a wearable | Limited | Strong | Delve |
| Human factors work on a home-use device | Limited | Strong | Delve |
Verdict: Velentium vs Delve
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
Delve (4.0/5) is worth a look if you need human factors work on a home-use device. If your situation matches that, Delve is a competitive option.
Related comparisons
Velentium vs Delve FAQ
Is Velentium better than Delve?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. Delve's strongest advantage: strong user research and industrial design, important for patient-worn devices.
How do Velentium and Delve differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. Delve uses time and materials, phased fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or Delve?
Delve is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and Delve?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Delve's primary differentiator is: design research and industrial design depth from two long-established US studios. They also differ in team size (51–250 vs 200–500), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Wearables & remote monitoring, Surgical & therapeutic devices).
Verify all details directly with each company before making a decision.